Insights

Emerging Market Focus Cassava Sciences is actively expanding its footprint in African markets through strategic partnerships with local entities like Zimbabwe's Strive Masiyiwa and Zindi, indicating a strong opportunity to offer tailored digital infrastructure and financial technology solutions that support high-growth regions.

Digital Payment Expansion The company's collaboration with Circle Internet Group to promote USDC and onchain payment infrastructure highlights potential sales avenues for blockchain and cryptocurrency service providers looking to support innovative global payment solutions.

Research and Clinical Innovation Cassava's focus on CNS disorder treatments and recent key hires in clinical development suggest opportunities to provide specialized healthcare technology, medical devices, or data management solutions to support their ongoing research pipeline.

Investment Opportunities Participation in global investment conferences and a recent funding round of $50 million demonstrate a readiness for scaling operations, creating a prospect for financial services, investor relations, and enterprise software tailored for biotech growth stages.

Technology Infrastructure With a modern tech stack including Akamai, React, and New Relic, Cassava Sciences showcases a commitment to digital innovation, opening doors for IT solution providers focused on cloud security, performance monitoring, and web development tools to enhance their infrastructure.

Cassava Sciences, Inc. Tech Stack

Cassava Sciences, Inc. uses 8 technology products and services including Akamai, React, DataTables, and more. Explore Cassava Sciences, Inc.'s tech stack below.

  • Akamai
    Content Delivery Network
  • React
    Javascript Frameworks
  • DataTables
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Underscore.js
    Javascript Libraries
  • New Relic
    Real User Monitoring
  • CKEditor
    Rich Text Editors
  • Akamai Bot Manager
    Security

Media & News

Cassava Sciences, Inc.'s Email Address Formats

Cassava Sciences, Inc. uses at least 2 format(s):
Cassava Sciences, Inc. Email FormatsExamplePercentage
FLast@cassavasciences.comJDoe@cassavasciences.com
82%
First@cassavasciences.comJohn@cassavasciences.com
18%
FLast@paintrials.comJDoe@paintrials.com
96%
Last@paintrials.comDoe@paintrials.com
4%

Frequently Asked Questions

What is Cassava Sciences, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Cassava Sciences, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cassava Sciences, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Cassava Sciences, Inc. is a publicly traded company; the company's stock symbol is SAVA.

What is Cassava Sciences, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Cassava Sciences, Inc.'s official website is cassavasciences.com and has social profiles on LinkedIn.

What is Cassava Sciences, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Cassava Sciences, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cassava Sciences, Inc. have currently?

Minus sign iconPlus sign icon
As of July 2026, Cassava Sciences, Inc. has approximately 37 employees across 4 continents, including North AmericaAfricaEurope. Key team members include Chairman Of The Board-Board: R. B.Director Information Technology: J. P.Senior Clinical Project Manager: B. M.. Explore Cassava Sciences, Inc.'s employee directory with LeadIQ.

What industry does Cassava Sciences, Inc. belong to?

Minus sign iconPlus sign icon
Cassava Sciences, Inc. operates in the Biotechnology Research industry.

What technology does Cassava Sciences, Inc. use?

Minus sign iconPlus sign icon
Cassava Sciences, Inc.'s tech stack includes AkamaiReactDataTablesModernizrUnderscore.jsNew RelicCKEditorAkamai Bot Manager.

What is Cassava Sciences, Inc.'s email format?

Minus sign iconPlus sign icon
Cassava Sciences, Inc.'s email format typically follows the pattern of FLast@cassavasciences.com. Find more Cassava Sciences, Inc. email formats with LeadIQ.

How much funding has Cassava Sciences, Inc. raised to date?

Minus sign iconPlus sign icon
As of July 2026, Cassava Sciences, Inc. has raised $257M in funding. The last funding round occurred on Nov 18, 2022 for $50M.

When was Cassava Sciences, Inc. founded?

Minus sign iconPlus sign icon
Cassava Sciences, Inc. was founded in 1998.
Cassava Sciences, Inc. logo

Cassava Sciences, Inc.

Biotechnology ResearchTexas, United States11-50 Employees

Cassava Sciences, Inc. is a biotechnology research company based in Austin, Texas. It is described as pursuing the development of new treatments for central nervous system disorders. The organization is relatively small and maintains an online presence at cassavasciences.com.

Publicly available information notes activity around partnerships, with recent reports in March 2026 describing a collaboration involving Cassava Sciences. The broader context includes engagement with other entities in the technology and biotech space, illustrating ongoing external collaborations. The provided list of similar companies places Cassava Sciences alongside larger biotechnology and pharmaceutical firms, reflecting its position within a landscape that includes major industry players.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
SAVA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1998
Employees
11-50

Section iconFunding & Financials

  • $257M

    Cassava Sciences, Inc. has raised a total of $257M of funding over 5 rounds. Their latest funding round was raised on Nov 18, 2022 in the amount of $50Mas a post_ipo_equity.

  • $10M$25M

    Cassava Sciences, Inc.'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $257M

    Cassava Sciences, Inc. has raised a total of $257M of funding over 5 rounds. Their latest funding round was raised on Nov 18, 2022 in the amount of $50Mas a post_ipo_equity.

  • $10M$25M

    Cassava Sciences, Inc.'s revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.